NYSE:SOLVMedical Equipment
Trian’s Push For Cuts And Buybacks Might Change The Case For Investing In Solventum (SOLV)
In late April 2026, activist investor Trian Fund Management, which owns nearly 5% of Solventum, issued an open letter urging the board to cut overheads, divest non-core assets such as Health Information Systems, and prioritize share repurchases to improve shareholder value after its spin-out from 3M.
The letter sharply criticizes how the separation from 3M was handled, arguing that it favored executive pay structures over shareholder outcomes and calling for a fundamental rethink of costs,...